Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TISSEEL to prevent complications after laparoscopic sleeve gastrectomy
2013-001361-16Phase 3Active
- Sponsor
- CHU Amiens-Picardie
- Start
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of tisseel in class III obesity (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoints: Prevention of gastric fistula, Prevention of intra-abdominal hemorrhage and 1 more. Started Apr 2014; status: active.
02
Drugs
tisseel
03
Conditions
class III obesity
Beyond the preview
Go deeper on 2013-001361-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001361-16.